0001193125-16-424986.txt : 20160108 0001193125-16-424986.hdr.sgml : 20160108 20160108164935 ACCESSION NUMBER: 0001193125-16-424986 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20160108 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160108 DATE AS OF CHANGE: 20160108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HCA Holdings, Inc. CENTRAL INDEX KEY: 0000860730 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 273865930 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11239 FILM NUMBER: 161333791 BUSINESS ADDRESS: STREET 1: ONE PARK PLZ CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6153449551 MAIL ADDRESS: STREET 1: ONE PARK PLAZA CITY: NASHVILLE STATE: TN ZIP: 37203 FORMER COMPANY: FORMER CONFORMED NAME: HCA INC/TN DATE OF NAME CHANGE: 20010627 FORMER COMPANY: FORMER CONFORMED NAME: HCA THE HEALTHCARE CO DATE OF NAME CHANGE: 20010419 FORMER COMPANY: FORMER CONFORMED NAME: COLUMBIA HCA HEALTHCARE CORP DATE OF NAME CHANGE: 20000502 8-K 1 d117575d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 8, 2016

 

 

HCA HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-11239   27-3865930

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

One Park Plaza, Nashville,

Tennessee

  37203
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (615) 344-9551

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02. Results of Operations and Financial Condition.

On January 8, 2016, HCA Holdings, Inc. (the “Company”) issued a press release previewing its fiscal 2015 results, including, among other matters, that it expects its Adjusted EBITDA to exceed its previously issued guidance of approximately $7.8 billion for 2015. Adjusted EBITDA for 2015 is now estimated to be approximately $7.9 billion. The text of the press release is set forth as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

The information set forth in Item 2.02 and Exhibit 99.1 is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit 99.1    Press Release, dated January 8, 2016.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

HCA HOLDINGS, INC.
 

/s/ William B. Rutherford

 

William B. Rutherford

Executive Vice President and Chief Financial Officer

Date: January 8, 2016


EXHIBIT INDEX

 

Exhibit 99.1    Press Release, dated January 8, 2016.
  
EX-99.1 2 d117575dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

 

   FOR IMMEDIATE RELEASE

INVESTOR CONTACT:

   MEDIA CONTACT:

Mark Kimbrough

   Ed Fishbough

615-344-2688

   615-344-2810

HCA Previews 2015 Results

Nashville, Tenn., January 8, 2016 – HCA Holdings, Inc. (NYSE: HCA) today announced that it expects its Adjusted EBITDA to exceed its previously issued guidance of approximately $7.8 billion for 2015. Adjusted EBITDA for 2015 is now estimated to be approximately $7.9 billion. The Company anticipates reporting its fourth quarter 2015 results of operations and guidance for 2016 on January 28, 2016.

Same facility admissions for the fourth quarter of 2015 are expected to increase approximately 1.6 percent, same facility equivalent admissions are expected to increase approximately 2.9 percent and same facility emergency room visits are expected to increase approximately 3.6 percent from the prior year’s fourth quarter.

The Company is scheduled to present Monday, January 11, at 8:00 am (PST) at the J.P. Morgan Healthcare Conference held at the Westin St. Francis Hotel in San Francisco, CA. A link to the live audio webcast is available and copies of the related presentation materials will be available at the Investor Relations section of the Company’s website, www.hcahealthcare.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include statements that do not relate solely to historical or current facts and are subject to finalization of the Company’s fourth quarter financial and accounting procedures. Forward-looking statements can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, (2) the effects related to the implementation of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the “Health Reform Law”), possible delays in or complications related to implementation of the Health Reform Law, court challenges, the possible enactment of additional federal or state health care reforms and possible changes to the


Health Reform Law and other federal, state or local laws or regulations affecting the health care industry, (3) the effects related to the continued implementation of the sequestration spending reductions required under the Budget Control Act of 2011 (the “BCA”), and related legislation extending these reductions, and the potential for future deficit reduction legislation that may alter these spending reductions, which include cuts to Medicare payments, or create additional spending reductions, (4) increases in the amount and risk of collectability of uninsured accounts and deductibles and copayment amounts for insured accounts, (5) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (6) possible changes in Medicare, Medicaid and other state programs, including Medicaid upper payment limit programs or waiver programs, that may impact reimbursements to health care providers and insurers, (7) the highly competitive nature of the health care business, (8) changes in service mix, revenue mix and surgical volumes, including potential declines in the population covered under managed care agreements, the ability to enter into and renew managed care provider agreements on acceptable terms and the impact of consumer driven health plans and physician utilization trends and practices, (9) the efforts of insurers, health care providers and others to contain health care costs, (10) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (11) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (12) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (13) changes in accounting practices, (14) changes in general economic conditions nationally and regionally in our markets, (15) the emergence and effects related to infectious diseases, including Ebola; (16) future divestitures which may result in charges and possible impairments of long-lived assets, (17) changes in business strategy or development plans, (18) delays in receiving payments for services provided, (19) the outcome of pending and any future tax audits, disputes and litigation associated with our tax positions, (20) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (21) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments, and (22) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2014 and our other filings with the Securities and Exchange Commission. Many of the factors that will determine our future results are beyond our ability to control or predict. In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

All references to “Company” and “HCA” as used throughout this release refer to HCA Holdings, Inc. and its affiliates.

GRAPHIC 3 g117575g37m61.jpg GRAPHIC begin 644 g117575g37m61.jpg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end